Munro J, Layton R, Owens L
Mol Biol (Mosk). 2005 Nov-Dec;39(6):1042-5.
This paper describes a technique for the development of a positive control for use in a nested PCR to show that the PCR has worked correctly with both outer and inner primers designed for diagnostic amplification of 618 bp and 317 bp products respectively. This positive control produces a larger product than the diagnostic sample that can be discriminated on an agarose gel. This technique is advantageous over traditional cloning of the diagnostic PCR product itself by: 1) making it visually easy to detect plasmid contamination and thus, prevent false positives from the plasmid; 2) develop a positive control when the target organism is at a very low prevalence so initial detection is not relied on for cloning positive controls. This will ensure the PCR is working correctly prior to diagnostic sampling, reducing false negatives; or 3) for developing a PCR and determining the sensitivity prior to the use of diagnostic samples. The methods used to produce this nested positive control demonstrates how to use large oligonucleotide primers in PCR without non-specific binding occurring.
本文描述了一种用于巢式聚合酶链反应(PCR)阳性对照的开发技术,以证明PCR分别使用为诊断扩增618bp和317bp产物而设计的外引物和内引物时能够正确工作。该阳性对照产生的产物比诊断样品更大,可在琼脂糖凝胶上进行区分。与传统克隆诊断PCR产物本身相比,该技术具有以下优势:1)在视觉上易于检测质粒污染,从而防止质粒产生假阳性;2)当目标生物的流行率非常低时开发阳性对照,因此不依赖初始检测来克隆阳性对照。这将确保在诊断采样之前PCR能够正确工作,减少假阴性;或者3)用于开发PCR并在使用诊断样品之前确定灵敏度。用于产生这种巢式阳性对照的方法展示了如何在PCR中使用大型寡核苷酸引物而不发生非特异性结合。